T. Jobo

发表

Expression of Cell Cycle Regulators in Endometrial Adenocarcinoma

H. Kuramoto, J. Watanabe, Y. Kamata, 2003 .

PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, Journal of Cancer Research and Clinical Oncology.

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

E. Ohno, H. Kuramoto, H. Sato, 2002, British Journal of Cancer.

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

H. Kuramoto, J. Watanabe, T. Jobo, 2002, Journal of Cancer Research and Clinical Oncology.

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

H. Kuramoto, J. Watanabe, Y. Kamata, 2003, Journal of Cancer Research and Clinical Oncology.

Adequacy evaluation of endometrial cytology using Thinlayer specimens

M. Hattori, I. Okayasu, J. Watanabe, 2008 .

Contributor Index Vol. 48, 2004

K. Chew, H. Kuramoto, R. Ashfaq, 2004, Acta Cytologica.

Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: A Japan Kanto Tumor Board study (JKTB trial)

Mitsuaki Suzuki, Tadao Tanaka, Chie Nagata, 2013, The journal of obstetrics and gynaecology research.

Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs.

R. Berkowitz, S. Mok, N. Yaegashi, 2007, Human pathology.

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

H. Kuramoto, I. Okayasu, Y. Kamata, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

H. Kuramoto, I. Okayasu, J. Watanabe, 2005, International Journal of Gynecologic Cancer.

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.

T. Jobo, D. Aoki, S. Kodama, 2013, The Lancet. Oncology.

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

H. Kuramoto, J. Watanabe, T. Kanai, 2005, International Journal of Gynecologic Cancer.

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).

Y. Niibe, T. Kanai, T. Jobo, 2007, Japanese journal of clinical oncology.

Conservative surgery for malignant ovarian tumor in women of childbearing age

H. Kuramoto, T. Kanai, T. Jobo, 2000, International Journal of Clinical Oncology.

Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer? Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial

T. Jobo, D. Aoki, K. Ochiai, 2011, International Journal of Gynecologic Cancer.

Lactation and risk of endometrial cancer in Japan: a case-control study.

N. Yaegashi, T. Jobo, S. Nagase, 2006, The Tohoku journal of experimental medicine.

Uterine Leiomyoma Causing Massive Ascites and Left Pleural Effusion with Elevated CA 125: A Case Report

H. Kuramoto, T. Jobo, H. Hata, 2000, The journal of obstetrics and gynaecology research.

Secondary acute leukemia following chemotherapy for ovarian cancer: report of five cases

H. Kuramoto, T. Jobo, H. Hata, 1999, International Journal of Clinical Oncology.

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).

M. Hatae, N. Yaegashi, I. Konishi, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase II study comparing docetaxel plus cisplatin , docetaxel plus carboplatin , and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma : a Japanese Gynecologic Oncology Group study ( JGOG 2041 )

M. Hatae, N. Yaegashi, I. Konishi, 2011 .

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study

H. Kuramoto, T. Jobo, D. Aoki, 2005, British Journal of Cancer.

Long-term follow-up of a randomized trial comparing conventional paclitaxel and carboplatin with dose-dense weekly paclitaxel and carboplatin in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: JGOG 3016 trial.

T. Jobo, H. Tsuda, D. Aoki, 2012 .

Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases.

T. Jobo, Y. Aoki, Y. Nagai, 2007, Gynecologic oncology.

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

H. Kuramoto, J. Watanabe, T. Kanai, 2004, International Journal of Gynecologic Cancer.

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

H. Kuramoto, J. Watanabe, T. Kanai, 2004, International Journal of Gynecologic Cancer.

Expression of Tumor Suppressor Gene Product p14ARF in Endometrioid Adenocarcinoma of the Uterine Corpus

H. Kuramoto, I. Okayasu, J. Watanabe, 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, Anticancer research.

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, International Journal of Gynecologic Cancer.

Basement Membrane–like Substance in Cytologic Diagnosis in Clear Cell Adenocarcinoma of the Minor Salivary Gland of the Palate

M. Hattori, H. Kuramoto, K. Iwabuchi, 2007, Acta Cytologica.

Contributor Index Vol. 51, 2007

M. Hattori, H. Kuramoto, K. Kapila, 2007, Acta Cytologica.

C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix.

Y. Saga, H. Kuramoto, T. Jobo, 2006, European journal of gynaecological oncology.

Coexisting clear cell adenocarcinoma and squamous cell carcinoma arising from ovarian endometriosis

H. Kuramoto, J. Watanabe, T. Jobo, 2000, International Journal of Clinical Oncology.

CYTOLOGIC SCORING OF ENDOMETRIOID ADENOCARCINOMA OF THE ENDOMETRIUM

M. Hattori, H. Kuramoto, J. Watanabe, 2004, International Journal of Gynecologic Cancer.

Effectiveness of Mass Screening for Endometrial Cancer

H. Kuramoto, I. Tsuji, A. Yajima, 2002, Acta Cytologica.

Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas

J. Kigawa, N. Yaegashi, Y. Terai, 2009, International Journal of Gynecologic Cancer.

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

T. Jobo, H. Tsuda, D. Aoki, 2009, The Lancet.

Endometrial cytology and biopsy in endometrial carcinoma diagnosis : advantages and disadvantages( Clinical usefulness of endometrial cytology and biopsy in the early detection of endometrial cancer)

T. Jobo, 2008 .

Study on the long-term follow-up of endometrial hyperplasia

H. Kuramoto, T. Jobo, K. Tateoka, 1996, International Journal of Clinical Oncology.

Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.

H. Kuramoto, T. Jobo, M. Imai, 2001, European journal of gynaecological oncology.

Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia.

H. Kuramoto, T. Jobo, S. Ohkawara, 2000, European journal of gynaecological oncology.

Clinicopathologic Relevance of Asymptomatic Endometrial Carcinoma

H. Kuramoto, T. Jobo, T. Arai, 2003, Acta Cytologica.

Cytological endometorial heperplasia with new classification. Cytopathological and clinical findings of endometrial hyperplasia.

E. Ohno, H. Kuramoto, T. Jobo, 1998 .

Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma.

Y. Saga, Mitsuaki Suzuki, Yoshifumi Takahashi, 2012, Oncology letters.

Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma--a case report.

Y. Niibe, T. Jobo, N. Unno, 2007, Anticancer research.

Aspiration Cytology of Malignant Fibrous Histiocytoma After Radiation Therapy for Carcinoma of the Uterine Cervix

H. Kuramoto, T. Jobo, M. Kawaguchi, 2004, Acta Cytologica.

Involvement of microsatellite instability in lymph node metastasis of endometrial carcinoma.

Y. Saga, Mitsuaki Suzuki, H. Kuramoto, 2002, Cancer genetics and cytogenetics.

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

H. Yoshikawa, T. Jobo, Y. Takei, 2014, International Journal of Clinical Oncology.

Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma

M. Hattori, H. Kuramoto, J. Watanabe, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

A 22/22 translocation carrier with recurrent abortions demonstrated by a Giemsa banding technique

T. Jobo, T. Maeda, M. Ohno, 1976, Human Genetics.

Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

Y. Ohashi, K. Hasegawa, K. Ushijima, 2009, Anticancer research.

Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501).

K. Matsuo, Y. Niibe, J. Watanabe, 2010, European journal of gynaecological oncology.

Concomitant Expression of HER2 and HIF-1 is a Poor Prognostic Factor in Uterine Cervical Carcinoma Treated with Concurrent Chemoradiotherapy: Prospective Analysis (KGROG0501)

K. Matsuo, Y. Niibe, J. Watanabe, 2008 .

Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose.

H. Kuramoto, Y. Niibe, T. Kanai, 2006, European journal of gynaecological oncology.

Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?

Y. Saga, H. Kuramoto, T. Jobo, 2006, Gynecologic oncology.

A comparative study of the usefulness of toki-shakuyaku-san and an oral iron preparation in the treatment of hypochromic anemia in cases of uterine myoma.

S. Onodera, S. Tashiro, T. Jobo, 2003, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Population Screening Program for Cancer of the Cervix Using a Mobile Office-Experience of 2 Million Cases

H. Kuramoto, F. Hirahara, T. Jobo, 2012 .

Parametrial spread is a prognostic factor in endometrial carcinoma.

H. Kuramoto, T. Jobo, R. Sato, 2003, European journal of gynaecological oncology.

Endometrial carcinoma with synchronous ovarian malignancy-differentiation between independent and metastatic carcinomas

H. Kuramoto, T. Jobo, Shouji Kamikatahira, 1996, International Journal of Clinical Oncology.

Early triple malignancies of the female genital tract: A case report

H. Kuramoto, T. Jobo, M. Arai, 1997, International Journal of Clinical Oncology.

Usefulness of Endometrial Aspiration Cytology for the Preoperative Diagnosis of Ovarian Carcinoma

E. Ohno, H. Kuramoto, T. Jobo, 1999, Acta Cytologica.

[Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer].

H. Kuramoto, T. Jobo, M. Arai, 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

Lymph node pathway in the spread of endometrial carcinoma.

H. Kuramoto, J. Watanabe, T. Jobo, 2005, European journal of gynaecological oncology.

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.

K. Matsuo, Y. Niibe, T. Jobo, 2007, European journal of gynaecological oncology.

Randomized phase III trial of conventional paclitaxel and carboplatin (c-TC) versus dose dense weekly paclitaxel and carboplatin (dd-TC) in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: Japanese Gynecologic Oncology

T. Jobo, H. Tsuda, D. Aoki, 2008 .

Clinical Significance of Human Papillomavirus Genotype by Linear Array Assay in Japanese Women With Uterine Cervical Lesions and Type 16 Physical Status by In Situ Hybridization

I. Okayasu, J. Watanabe, Y. Nishimura, 2009, International Journal of Gynecologic Cancer.

[Epidemiology of endometrial carcinoma].

H. Kuramoto, T. Kanai, T. Jobo, 2004, Nihon rinsho. Japanese journal of clinical medicine.